Africa

DOCTORS WITHOUT BORDERS                                                                              Nov. 12, 2014

The international medical organisation Médecins Sans Frontières (MSF) or Doctors Without Borders has posted an online briefing on Ebola for aid workers involved in the battle against the haemorrhagic fever. This briefing package is now available to anyone wishing to gain a basic understanding of the virus and how it can be contained.

http://www.msf.org/article/ebola-online-briefing-now-available-public

LOS ANGELES TIMES                                           Nov. 12, 2014
By Matt Hansen
Weighing President Obama’s request for billions of dollars in new funding to combat the Ebola virus, lawmakers on Wednesday pressed federal agencies to explain how the additional money would help in the fight against the disease.

Members of the Senate Appropriations Committee debated Obama’s request for $6.18 billion in additional funds to battle the virus, which has infected more than 13,000 people, mostly in West Africa...

Health and Human Services Secretary Sylvia Mathews Burwell and Homeland Security Secretary Jeh Johnson appear before the Senate Appropriations Committee during a hearing Tuesday in Washington over the government's response to Ebola. (Michael Reynolds / European Pressphoto Agency)

... the request faced skeptical lawmakers who questioned whether additional money would be well spent by a federal government that has struggled at times with containing the epidemic.

“Instead of an effective response, what we’ve witnessed from various agencies is confusing and at times contradictory plans,” Sen. Richard C. Shelby (R-Ala.) said.

USA TODAY                                         Nov. 12, 2014
by Liz Sazbo

Doctors Without Borders will begin clinical trials of three experimental Ebola therapies in West Africa in December, the aid group announced Wednesday.

The studies, to be conducted at the group's treatment centers in Guinea and Liberia, will test therapies already used in some Ebola patients in the USA and Europe: the antiviral drugs brincidofovir and favipiravir, as well as blood donations from Ebola survivors.

Brincidofovir, made by Chimerix of North Carolina, was given to cameraman Ashoka Mukpo, Liberian national Thomas Eric Duncan and physician Craig Spencer. Mukpo and Spencer survived. Duncan received the drug just a couple days before he died.

Favipiravir, an anti-flu drug made by Japan's Fujifilm Holding Corp., was given to a French nurse who worked with Doctors Without Borders.

And blood donations from Ebola survivors, which contain antibodies against the virus, have been used since the first Ebola outbreak in 1976.

Read complete story
http://www.usatoday.com/story/news/nation/2014/11/12/ebola-clinical-trial/18919401/

THE HILL                                                          Nov. 12, 2014
Commentary by Claire Pomeroy, M.D., M.B.A, President of the Albert and Mary Lasker Foundation.

...Without a commitment by Congress to fund basic medical research, the lives of millions are put at risk, along with the nation’s economic and national security. Outbreaks of deadly viruses – including AIDS or Ebola – have shown us the costs of not remaining vigilant.

  So how much funding is enough? It’s time for us to have that national conversation once again. We do not know what the superbugs of tomorrow will look like. But we do know that novel pathogens will emerge or existing ones will mutate, and that as global travel and migration inexorably increase, disease knows no border. It is time for us to stop chasing at AIDS and Ebola from behind, and take stock of our capacity to commit.